Overview

Intravenous Regional Analgesia of Dexmedetomidine

Status:
NOT_YET_RECRUITING
Trial end date:
2027-08-30
Target enrollment:
Participant gender:
Summary
Dexmedetomidine is a highly selective -adrenergic receptor agonist that exerts its effects by inhibiting the release of norepinephrine at presynaptic nerve terminals, leading to reduced sympathetic activity; This mechanism results in analgesia, sedation, and anxiolysis without significant respiratory depression
Phase:
NA
Details
Lead Sponsor:
Mansoura University
Treatments:
Dexmedetomidine
Saline Solution